At present, the activation of TLR2 is generally believed to increase the expression of proinflammatory cytokines and participate in signaling pathways important in the main injury response period of oral mucositis induced by radiotherapy and chemotherapy (Villa and Sonis, 2016). Here, TLR2 is linked to oral mucositis.